Definitive Contract 75N91022C00052

Award Date 8/25/22
Potential Completion Date 5/31/25
Potential Value $1.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Naperville, IL 60564, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed

The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.

Generated 9/11/24, 9:12 AM